paclitaxel

Documents about paclitaxel

• Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis#877474ClinicalTrials.gov
• Sarcopenia and Paclitaxel-Induced Neuropathy in Early Stage Breast Cancer (Neuro-Sarc)#804691ClinicalTrials.gov
• Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6#1095965ClinicalTrials.gov
• Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?#1101918ClinicalTrials.gov
• Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy#864551ClinicalTrials.gov
• Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)#1071941ClinicalTrials.gov
• Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment#1151066ClinicalTrials.gov
• Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel#1101380ClinicalTrials.gov
• A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma#1309645ClinicalTrials.gov
• Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer#845481ClinicalTrials.gov
• Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease#858081ClinicalTrials.gov
• EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer#862839ClinicalTrials.gov
• Role of Curcumin in Paclitaxel Induced PN#882017ClinicalTrials.gov
• Cisplatin vs Paclitaxel for Triple Negative Breast Cancer#1294889ClinicalTrials.gov
• Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer#982586ClinicalTrials.gov
• Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)#1059471ClinicalTrials.gov
• Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer#1073409ClinicalTrials.gov
• Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments#1093353ClinicalTrials.gov
• Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC#1164473ClinicalTrials.gov
• Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer#876089ClinicalTrials.gov
• Study of Weekly LOC-paclitaxel Injection for Melanoma#1162321ClinicalTrials.gov
• Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma#1280918ClinicalTrials.gov
• Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer#863425ClinicalTrials.gov
• Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma#1086047ClinicalTrials.gov
• Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer#256863ClinicalTrials.gov
• Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy#917772ClinicalTrials.gov
• Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy#1163737ClinicalTrials.gov
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread#1162459ClinicalTrials.gov
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma#855219ClinicalTrials.gov
• Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer#865487ClinicalTrials.gov
• Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies#1101147ClinicalTrials.gov
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer#1197341ClinicalTrials.gov
• A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer#1184215ClinicalTrials.gov
• Paclitaxel-induced neuroinflammation after systemic administration in male and female mice#630428HAL (France)
• Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer#802689ClinicalTrials.gov
• A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors#833636ClinicalTrials.gov
• A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC#864700ClinicalTrials.gov
• Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma#979090ClinicalTrials.gov
• Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer#1007602ClinicalTrials.gov
• Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus#1231061ClinicalTrials.gov
• The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression#830061ClinicalTrials.gov
• Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer#249581ClinicalTrials.gov
• Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction#835534ClinicalTrials.gov
• Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer#1009150ClinicalTrials.gov
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL#1033425ClinicalTrials.gov
• Paclitaxel-bevacizumab in Advanced Lung Cancer#1045371ClinicalTrials.gov
• Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma#1162967ClinicalTrials.gov
• Clinical Study of Liposomal Paclitaxel in Chinese Patients#1230680ClinicalTrials.gov
• Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer#909205ClinicalTrials.gov
• Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer#898458ClinicalTrials.gov